Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

BACKGROUND: We studied the comparative effectiveness of biosimilar filgrastim vs original filgrastim in patients with chemotherapy-induced neutropenia. PATIENTS AND METHODS: This multicenter, observational study was conducted at 14 centers. The study included 337 patients experiencing neutropenia un...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Onco Targets Ther
Main Authors: Sevinç, Alper, Özkan, Metin, Özet, Ahmet, Dane, Faysal, Öksüzoğlu, Berna, Işıkdoğan, Abdurrahman, Özdemir, Feyyaz, Uncu, Doğan, Gümüş, Mahmut, Evrensel, Türkkan, Yaren, Arzu, Kara, Oğuz, Tekin, Salim Başol
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2018
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5783019/
https://ncbi.nlm.nih.gov/pubmed/29403286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S106342
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares